Release Date: 07/02/19 09:53 Summary: FINANCIAL SERVICES ROYAL COMMISSION Price Sensitive: Yes Download Document 130.72KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%